Trademark Overview
On Thursday, March 14, 2024, a trademark application was filed for VASCUDYNE with the United States Patent and Trademark Office. The USPTO has given the VASCUDYNE trademark a serial number of 98449022. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, January 13, 2026. This trademark is owned by Vascudyne, Inc.. The VASCUDYNE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
(Based on Intent To Use) Agents for medical purposes, namely, biotechnologically engineered tissue products in the nature of cells and tissue cell sheets for the treatment of cardiac disease and conditions; biological tissue implants comprising living tissue for medical and cosmetic purposes; biotechnologically engineered tissue products, namely, cells and tissue cell sheets for medical use; regenerative biological tissue sheets for medical purposes; surgical implants comprised of living tissue; transcatheter implants comprised of living tissue; biological material, namely, tissue sheets for the treatment of wounds; biological material, namely, cells and tissue cell sheets for the treatment of damaged skin and tissue; biological tissue grafts; vascular grafts
(Based on Intent To Use) Surgical apparatus; surgical apparatus for medical or veterinary use; medical and surgical apparatus, namely, implantable artificial cardiac valves; medical apparatus for use in percutaneous and endovascular procedures; medical apparatus for use in cardiovascular procedures; medical apparatus for treating cardiovascular disease; cardiac valves for surgical prostheses; prostheses for cardiovascular systems, namely, for the heart and heart valves; artificial cardiac valves for implantation as part of the cardiovascular system; subcutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; valve implants consisting of artificial materials for implementation as part of the cardiovascular system; medical devices for use in treating cardiac disease; replacement tissue valves being implants comprising artificial and natural, non-living materials for the human heart; catheters
(Based on Use in Commerce) Scientific research and development; biomedical research and development
